Sorintellis logo — AI-Powered Pharmaceutical Portfolio Management

Sorintellis

AI-Powered Pharmaceutical Portfolio Management

Founded 2022 Canada Montreal, Canada 3 employees AI, Biotechnology +3

General Information

Company Name Sorintellis
Founded Year 2022
Location Canada Montreal, Canada
Employees 3
Industries AI, Biotechnology, Life Sciences +2
Social

BounceWatch is an independent company data service, not affiliated with Sorintellis. To contact Sorintellis, visit sorintellisgroup.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sorintellis compare?

A PDF of Sorintellis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sorintellis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sorintellis

Sorintellis, founded in 2022 and headquartered in Canada, is making significant strides in the pharmaceutical portfolio management (PPM) sector. Utilizing a groundbreaking AI-powered decision support system, this Montreal-based company seeks to tackle the complex issues associated with drug development, offering a transformative solution through explainable machine learning.

Their mission focuses on aiding pharmaceutical companies, contract research organizations (CROs), and life sciences mezzanine investment funds with sophisticated AI tools designed for due diligence and strategic scenario assessment. The company's unique drug development risk network (DDRNAi) technology is poised to provide integral insights, facilitating crucial "Go/No Go" decisions.

By streamlining drug clinical development, Sorintellis presents significant investment potential within the AI, Biotechnology, and Life Sciences industries, without any recent funding rounds disclosed.

Business keywords: AI-powered Technology, Pharmaceutical Portfolio Management, Drug Development, Clinical Trials, Decision-Making, Artificial Intelligence (AI)

No funding data available for Sorintellis yet.

Sorintellis Alternatives & Competitors

View All Alternatives
Sorintellis vs
Intelligencia AI
Intelligencia AI United States

Applying machine learning in drug development

Series A
112 employees
AI, Big Data
Sorintellis vs

Strategies and technologies driving drug discovery to market.

10 employees
Biotechnology, Pharmaceutical
Sorintellis vs

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipe...

Post-IPO Equity
277 employees
Biotechnology, Health Care

FAQ About Sorintellis

AI-Powered Pharmaceutical Portfolio Management
Sorintellis was founded in 2022.
Sorintellis is headquartered in Montreal, Canada.
Sorintellis operates in AI, Biotechnology, Life Sciences, Pharmaceutical and Machine Learning. Its work centres on AI-powered Technology, Pharmaceutical Portfolio Management, Drug Development and Clinical Trials.
Sorintellis has approximately 3 employees.
Top alternatives and competitors to Sorintellis include Intelligencia AI, Drug Discovery & Development, Syndax Pharmaceuticals, Entera Bio Ltd., Elite Clinical Studies, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sorintellis and Intelligencia AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sorintellis, https://bouncewatch.com/company/sorintellis, updated 28 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes